This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 May;7(3):662-663.

doi: 10.1016/j.euf.2020.04.010. Epub 2020 May 13.

Reply to Cosimo De Nunzio, Giacomo Novara, Rocco Damiano, Riccardo Bartoletti, Andrea Tubaro, and Vincenzo Ficarra's Letter to the Editor re: Giorgio Ivan Russo, Carmen Scandura, Marina Di Mauro, et al. Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2020.01.002. New Evidence Changing Clinical Practice or Misunderstanding of Statistical Analyses? The Case of Serenoa repens and α-Blockers

Giorgio Ivan Russo¹, Giovanni Cacciamani², Andrea Cocci³

Affiliations

Affiliations

¹ Urology Section, University of Catania, Catania, Italy. Electronic address: giorgioivan1987@gmail.com.
² Department of Urology, University of Southern California, Los Angeles, CA, USA.
³ Department of Urology, University of Florence, Florence, Italy.

PMID: 32417122
DOI: 10.1016/j.euf.2020.04.010

Comment

Reply to Cosimo De Nunzio, Giacomo Novara, Rocco Damiano, Riccardo Bartoletti, Andrea Tubaro, and Vincenzo Ficarra's Letter to the Editor re: Giorgio Ivan Russo, Carmen Scandura, Marina Di Mauro, et al. Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2020.01.002. New Evidence Changing Clinical Practice or Misunderstanding of Statistical Analyses? The Case of Serenoa repens and α-Blockers

Giorgio Ivan Russo et al. Eur Urol Focus. 2021 May.

. 2021 May;7(3):662-663.

doi: 10.1016/j.euf.2020.04.010. Epub 2020 May 13.

Authors

Giorgio Ivan Russo¹, Giovanni Cacciamani², Andrea Cocci³

Affiliations

¹ Urology Section, University of Catania, Catania, Italy. Electronic address: giorgioivan1987@gmail.com.
² Department of Urology, University of Southern California, Los Angeles, CA, USA.
³ Department of Urology, University of Florence, Florence, Italy.

PMID: 32417122
DOI: 10.1016/j.euf.2020.04.010

No abstract available

PubMed Disclaimer

Comment on

Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials.
Russo GI, Scandura C, Di Mauro M, Cacciamani G, Albersen M, Hatzichristodoulou G, Fode M, Capogrosso P, Cimino S, Marcelissen T, Cornu JN, Gacci M, Minervini A, Cocci A; European Association of Urology Young Academic Urologists (EAU-YAU) Men’s Health and Functional Urology Working Groups. Russo GI, et al. Eur Urol Focus. 2021 Mar;7(2):420-431. doi: 10.1016/j.euf.2020.01.002. Epub 2020 Jan 15. Eur Urol Focus. 2021. PMID: 31952967
Re: Giorgio Ivan Russo, Carmen Scandura, Marina Di Mauro, et al. Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2020.01.002: New Evidence Changing Clinical Practice or Misunderstanding of Statistical Analyses? The Case of Serenoa repens and α-Blockers.
De Nunzio C, Novara G, Damiano R, Bartoletti R, Tubaro A, Ficarra V; members of the Research Urological Network. De Nunzio C, et al. Eur Urol Focus. 2021 Jul;7(4):894-896. doi: 10.1016/j.euf.2020.03.011. Epub 2020 May 14. Eur Urol Focus. 2021. PMID: 32418876 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program